Recent Episodes
The Pharmacist’s Role on the Blood Cancer Treatment Team
Peter Campbell, PharmD, BCOP, Columbia University Irving Medical Center, New York, NY
A Conversation on Multiple Myeloma with Edward Stadtmauer, MD
Edward A. Stadtmauer, MD, The University of Pennsylvania, Philadelphia, PA
The COVID-19 Vaccine and Your Patient with Cancer
Michael Angarone, DO, FIDSA, Feinberg School of Medicine, Chicago, IL
Managing Treatment for Patients with Relapsed/Refractory Lymphoma
Sonali M. Smith, MD, FASCO, The University of Chicago, Chicago, IL
What’s New in Treatment for Acute Myeloid Leukemia (AML)
Olatoyosi Odenike, MD and Wendy Stock, MD
Progress in the Treatment of Follicular Lymphoma
Jeff Sharman, MD, Willamette Valley Cancer Institute, Eugene, OR
Categories
- All Episodes (92)
- CAR T-cell Therapy (10)
- Clinical Trials (4)
- COVID-19 (7)
- General Treatment & Support (31)
- Genomics (3)
- Health Equity (7)
- Leukemia (22)
- Lymphoma (13)
- Minimal Residual Disease (MRD) (4)
- Myelodysplastic Syndromes (5)
- Myeloma & Amyloidosis (12)
- Myeloproliferative Neoplasms (3)
- Pediatric and AYA (12)
- Rare Blood Cancers (4)
- Transplantation (4)
- Waldenström macroglobulinemia (2)